Neuralink may begin human trials after receiving FDA approval

Neuralink is Elon Musk’s company that aims to develop an interface that allows people to control modern technology with their thoughts. It’s not supposed to be about things for fun, but about helping people who have various disabilities or injuries. It was founded in 2016, and as is already evident with Musk, his predictions and deadlines did not work out well here either. The first human tests of the technology were supposed to take place in 2020, later it was set for 2022, now it is 2023, and only now has Neuralink finally received permission to conduct such tests from the Food and Drug Administration (FDA).


Let us recall that the technology was already successfully tested on a macaque, but it also had several missteps. One was a recent investigation for violations of the Hazardous Substances Act. However, the FDA requires Neuralink to address further issues such as the safety of the lithium battery, preventing the wires from moving in the brain, and ensuring that the implant can be removed safely without damaging the brain. The company is not currently recruiting any patients to participate in the first trials, but should release more information about such recruitments soon.

Source: Svět hardware by

*The article has been translated based on the content of Svět hardware by If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!

*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.

*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!